Arch Therapeutics Reports on Current Activities CAMBRIDGE, MA--(Marketwired - Jul 30, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...